MIR3166

Across TCGA pan-cancer cohorts, MIR3166 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR3166 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR3166 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3166 expression acts as an unfavorable survival marker.

MESO, THYM, and KIRC are the cancer types where MIR3166 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	II,III,IV	0.067	0.382	<.001	126	view →
THYM	OS	Tertile	III,IV	0.103	0.944	<.001	108	view →
KIRC	DFS	Tertile	IV	0.147	0.639	.009	78	view →
LGG	OS	Tertile	All	0.420	0.815	<.001	54	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
THCA	OS	Tertile	All	0.240	0.931	.007	27	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	24	view →
CHOL	DFS	Tertile	All	0.037	0.486	.001	18	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	18	view →
LAML	DFS	Tertile	All	0.027	0.583	<.001	18	view →
ACC	DFS	Tertile	II,III,IV	0.242	0.724	.034	18	view →
BLCA	OS	Tertile	IV	0.249	0.591	.046	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MIR3166–MESO (DFS)

Open the MESO breakdown →